Comparison of the Effectiveness of Pre-urodynamic Single-dose Levofloxacin with Post-urodynamic Levofloxacin for Three Days Related to the Incidence of Urinary Tract Infection: A Randomized Control Trial
The current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related to the incidence of urinary tract infections post-urodynamic examination. This is a single-blind randomized clinical trial conducted in three outpati...
Saved in:
Published in | Urology journal Vol. 20; no. 3; pp. 167 - 172 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Iran
Urology and Nephrology Research Center
21.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related to the incidence of urinary tract infections post-urodynamic examination.
This is a single-blind randomized clinical trial conducted in three outpatient urology centers in Jakarta: Cipto Mangunkusumo General Hospital, Siloam Asri Hospital, and Persahabatan General Hospital using a consecutive sampling method between July 2019 - February 2022. The outcome of the study is the incidence of urinary tract infections in both treatment groups. Urinary tract infection was defined as a patient with one or more clinical symptoms of lower urinary tract infection and one or more urinalysis parameters positive for urinary tract infections. Chi-square was used to evaluate the association where p < 0.05 was used to determine statistical significance.
A total of 126 patients (63 patients in each arm) were included in the evaluation and analysis. Overall, urinary tract infections were detected in 25 cases (19.8%), 12 patients from the pre-urodynamic antibiotic group (9.5%) and 13 patients from the post-urodynamic antibiotic group (10.3%) (P = .823). E.coli was the most common bacteria found in the urine culture.
There is no significant difference between a single dose of 500 mg of Levofloxacin administered one hour before the urodynamic study and a once-daily dose of 500 mg of Levofloxacin for three days following the urodynamic study related to urinary tract infections prevention post-urodynamic examination. |
---|---|
AbstractList | The current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related to the incidence of urinary tract infections post-urodynamic examination.
This is a single-blind randomized clinical trial conducted in three outpatient urology centers in Jakarta: Cipto Mangunkusumo General Hospital, Siloam Asri Hospital, and Persahabatan General Hospital using a consecutive sampling method between July 2019 - February 2022. The outcome of the study is the incidence of urinary tract infections in both treatment groups. Urinary tract infection was defined as a patient with one or more clinical symptoms of lower urinary tract infection and one or more urinalysis parameters positive for urinary tract infections. Chi-square was used to evaluate the association where p < 0.05 was used to determine statistical significance.
A total of 126 patients (63 patients in each arm) were included in the evaluation and analysis. Overall, urinary tract infections were detected in 25 cases (19.8%), 12 patients from the pre-urodynamic antibiotic group (9.5%) and 13 patients from the post-urodynamic antibiotic group (10.3%) (P = .823). E.coli was the most common bacteria found in the urine culture.
There is no significant difference between a single dose of 500 mg of Levofloxacin administered one hour before the urodynamic study and a once-daily dose of 500 mg of Levofloxacin for three days following the urodynamic study related to urinary tract infections prevention post-urodynamic examination. Purpose: The current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related to the incidence of urinary tract infections post-urodynamic examination. Materials and Methods: This is a single-blind randomized clinical trial conducted in three outpatient urology centers in Jakarta: Cipto Mangunkusumo General Hospital, Siloam Asri Hospital, and Persahabatan General Hospital using a consecutive sampling method between July 2019 - February 2022. The outcome of the study is the incidence of urinary tract infections in both treatment groups. Urinary tract infection was defined as a patient with one or more clinical symptoms of lower urinary tract infection and one or more urinalysis parameters positive for urinary tract infections. Chi-square was used to evaluate the association where p < 0.05 was used to determine statistical significance. Results: A total of 126 patients (63 patients in each arm) were included in the evaluation and analysis. Overall, urinary tract infections were detected in 25 cases (19.8%), 12 patients from the pre-urodynamic antibiotic group (9.5%) and 13 patients from the post-urodynamic antibiotic group (10.3%) (P = .823). E.coli was the most common bacteria found in the urine culture. Conclusion:There is no significant difference between a single dose of 500 mg of Levofloxacin administered one hour before the urodynamic study and a once-daily dose of 500 mg of Levofloxacin for three days following the urodynamic study related to urinary tract infections prevention post-urodynamic examination. PURPOSEThe current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related to the incidence of urinary tract infections post-urodynamic examination. MATERIALS AND METHODSThis is a single-blind randomized clinical trial conducted in three outpatient urology centers in Jakarta: Cipto Mangunkusumo General Hospital, Siloam Asri Hospital, and Persahabatan General Hospital using a consecutive sampling method between July 2019 - February 2022. The outcome of the study is the incidence of urinary tract infections in both treatment groups. Urinary tract infection was defined as a patient with one or more clinical symptoms of lower urinary tract infection and one or more urinalysis parameters positive for urinary tract infections. Chi-square was used to evaluate the association where p < 0.05 was used to determine statistical significance. RESULTSA total of 126 patients (63 patients in each arm) were included in the evaluation and analysis. Overall, urinary tract infections were detected in 25 cases (19.8%), 12 patients from the pre-urodynamic antibiotic group (9.5%) and 13 patients from the post-urodynamic antibiotic group (10.3%) (P = .823). E.coli was the most common bacteria found in the urine culture. CONCLUSIONThere is no significant difference between a single dose of 500 mg of Levofloxacin administered one hour before the urodynamic study and a once-daily dose of 500 mg of Levofloxacin for three days following the urodynamic study related to urinary tract infections prevention post-urodynamic examination. |
Author | Widia, Fina Soedarman, Soefiannagoya Rizaly, Ahmad Aulia Leonardo, Kevin Rahardjo, Harrina Erlianti Purwanto, Haryo Prakoso Adhi Manurung, Mega Anara Wicaksono, Indra Afriansyah, Andika |
Author_xml | – sequence: 1 givenname: Harrina Erlianti surname: Rahardjo fullname: Rahardjo, Harrina Erlianti email: harrinaerlianti@gmail.com organization: Department of Urology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. harrinaerlianti@gmail.com – sequence: 2 givenname: Fina surname: Widia fullname: Widia, Fina email: finawidia@yahoo.com organization: Department of Urology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. finawidia@yahoo.com – sequence: 3 givenname: Mega Anara surname: Manurung fullname: Manurung, Mega Anara email: anaramanurung@gmail.com organization: Department of Urology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. anaramanurung@gmail.com – sequence: 4 givenname: Indra surname: Wicaksono fullname: Wicaksono, Indra email: indraw.93@gmail.com organization: Department of Urology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. indraw.93@gmail.com – sequence: 5 givenname: Soefiannagoya surname: Soedarman fullname: Soedarman, Soefiannagoya email: soefiannagoya@hotmail.com organization: Department of Urology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. soefiannagoya@hotmail.com – sequence: 6 givenname: Haryo Prakoso Adhi surname: Purwanto fullname: Purwanto, Haryo Prakoso Adhi email: prakoso.haryo7@gmail.com organization: Department of Urology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. prakoso.haryo7@gmail.com – sequence: 7 givenname: Ahmad Aulia surname: Rizaly fullname: Rizaly, Ahmad Aulia email: rizaly.aulia@gmail.com organization: Department of Urology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. rizaly.aulia@gmail.com – sequence: 8 givenname: Kevin surname: Leonardo fullname: Leonardo, Kevin email: kevinleonardosoputro@gmail.com organization: Division of Urology, Department of Surgery, Persahabatan Hospital, Jakarta, Indonesia. kevinleonardosoputro@gmail.com – sequence: 9 givenname: Andika surname: Afriansyah fullname: Afriansyah, Andika email: andikaafriansyah@gmail.com organization: Division of Urology, Department of Surgery, Persahabatan Hospital - Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. andikaafriansyah@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36461695$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkUlvEzEUgC1URBc4ckWWuHCZMF7G9nCr0tJWikRVgsRt5NhviKMZO9ieQPiL_Km6bZCA09u-t5-iIx88IPSa1DNKaybfT5vZjrRuJqlSz9AJkaypGi6-Hh10wmp1jE5T2tR1UwzxAh0zwQURbXOCfs_DuNXRpeBx6HFeA77sezDZ7cBDSg_O2wjVFIPdez06gz87_22AyoYEeAG70A_hpzbO4x8ur_FtSPlv-h-iDxEv1xEAX-h9wncw6AwW5_DY-MYbZ8EbeGj6JTqv4x4voza5hB5nCv4DPsd32tswul8lcx58jmEolNPDS_S810OCVwd5hpYfL5fz62rx6epmfr6otoqXe1hhesKJACbNCghveyKkbQhdUW6JtJQzRVvDNGsVEQQ0lZRLyaFuBQjNztC7p7LbGL5PkHI3umRgGLSHMKWOSi5Yy0UtCvr2P3QTpujLcB1VpG1qpRpZqDcHalqNYLttdGNZvfvzJXYPo_yYkQ |
ContentType | Journal Article |
Copyright | Copyright Urology and Nephrology Research Center May-Jun 2023 |
Copyright_xml | – notice: Copyright Urology and Nephrology Research Center May-Jun 2023 |
DBID | CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU CWDGH FYUFA GHDGH K9. M0S M1P PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.22037/uj.v19i.7288 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central ProQuest One Community College Middle East & Africa Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library Middle East & Africa Database ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest One Academic Eastern Edition MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: ProQuest Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1735-546X |
EndPage | 172 |
ExternalDocumentID | 36461695 |
Genre | Randomized Controlled Trial Journal Article |
GroupedDBID | --- 2WC 3V. 53G 6PF 7X7 88E 8FI 8FJ 8R4 8R5 AAWTL ABDBF ABUWG ADBBV AENEX AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS BAWUL BENPR BPHCQ BVXVI CCPQU CGR CUY CVF CWDGH DIK E3Z EBD ECM EIF EMOBN EOJEC ESX F5P FYUFA GROUPED_DOAJ HMCUK M1P M~E NPM OBODZ OK1 PQQKQ PROAC PSQYO Q2X RNS SV3 TR2 TUS UKHRP 7XB 8FK ALIPV K9. PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-p845-1d6cf1416e37cbe149f167d512b24d17d243829c3a398161ea2724774e096e6a3 |
IEDL.DBID | BENPR |
ISSN | 1735-1308 |
IngestDate | Fri Jun 28 03:08:41 EDT 2024 Fri Sep 13 03:44:03 EDT 2024 Thu May 23 23:34:41 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-p845-1d6cf1416e37cbe149f167d512b24d17d243829c3a398161ea2724774e096e6a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
PMID | 36461695 |
PQID | 2819508857 |
PQPubID | 105751 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2746394606 proquest_journals_2819508857 pubmed_primary_36461695 |
PublicationCentury | 2000 |
PublicationDate | 2023-May-21 |
PublicationDateYYYYMMDD | 2023-05-21 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-May-21 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | Iran |
PublicationPlace_xml | – name: Iran – name: Tehran |
PublicationTitle | Urology journal |
PublicationTitleAlternate | Urol J |
PublicationYear | 2023 |
Publisher | Urology and Nephrology Research Center |
Publisher_xml | – name: Urology and Nephrology Research Center |
SSID | ssj0051306 |
Score | 2.3178782 |
Snippet | The current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related to the... Purpose: The current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related... PURPOSEThe current study aims to compare the effectiveness of pre-urodynamic single-dose levofloxacin and post-urodynamic levofloxacin for three days related... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 167 |
SubjectTerms | Anti-Bacterial Agents - therapeutic use Antibiotics Humans Incidence Levofloxacin - therapeutic use Single-Blind Method Urinary tract diseases Urinary tract infections Urinary Tract Infections - epidemiology Urinary Tract Infections - etiology Urinary Tract Infections - prevention & control Urodynamics Urogenital system |
Title | Comparison of the Effectiveness of Pre-urodynamic Single-dose Levofloxacin with Post-urodynamic Levofloxacin for Three Days Related to the Incidence of Urinary Tract Infection: A Randomized Control Trial |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36461695 https://www.proquest.com/docview/2819508857/abstract/ https://search.proquest.com/docview/2746394606 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwELZ6SIiXipstZWUkXtM2jhPHvKB227JCUFVlK_Zt5WMiFbXxdo8K-Iv8qc7Y2QIS4ilRPLElH-NvPOP5GHtrXQGNF0RAvF9mUts8s8bnWW1LkK6ofONjlO9pNbyQH8fleI0NV3dhKKxypROjovbB0Rn5XnT44JJAA95YOgVwi73305uM-KPIz9qRaayzTZFLcthuHh6fnp2vtHKJujreNFJFmeF7nfJtCkEJfpbfdm9zfbmrREfA8k-kGXeck0dsq4OK_CCN7WO2Bu0T9uBz5wx_yn4N7jkEeWg4IjmechF3Cow-ns0gW6KOTLzz_AtuVFeQ-TAH_gluQ3MVvhusjdNxLCfi3j-l_5JAcMtHOPDAj8yPOY9BdOD5IsSGUc0kdlJq9GIWL_nyEXUfFqVwr_YdP-DnpvXh-vIn_jlIQfIohUvgGRudHI8Gw6zjZsimtcQe9JVrqJ-hUM4CmllNXimP6MEK6XPlBTkYtStMoWsElWCEEhKhJqDJBJUpnrONNrTwknEryRW470pXa-l1XQOQzkXcarV3pe6xndWATLr1NZ_8ng099ua-GFcGuTtMC2GJMkoi_JJoofXYizSQk2lK4TEpKlnllS63_1_5K_aQ6OUpWkDkO2xjMVvCawQhC9tn62qs-t0sw-fg69GHYT-a9HdqE-PW |
link.rule.ids | 315,786,790,870,12083,21416,27957,27958,31754,31755,33779,33780,43345,43840,74102,74659 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSMAFlfdCASNxdWn8iGMuVbWlWmBbIUilvUWJPZGKSrzso6L8Rf4U40cXkBC3KJ7YUsYef-MZz0fIq84K6B0PBMR7iknTFaxrXcGqToG0onS9i1m-J-XkVL6fqVk-cFvmtMormxgNtfM2nJG_jgEfXBJK78-_scAaFaKrmULjOrkhhZAhpU_PNg6XQvscbxdpoRg-V6nGJuehqM_6y-5FYc52Nc-kK_9El3GXOdomdzI8pAdJn3fJNRjukZvHOQB-n_wcb3gDqe8pojea6g9noxVeflwAW6NdTFzz9DNuTufAnF8CncKF78_99xZ7o-EIlgay3j-l_5JAQEtrVDbQw_ZySWPiHDi68nFgNC2JkTQMerqIF3tpHW5dYVNK8Rre0AP6qR2c_3r2A78cp8R4lMJp_4DUR2_r8YRlPgY2ryT-QVfavkAAB0LbDtC16otSO0QMHZeu0I6HoKKxohWmQiAJLddcIrwEdJOgbMVDsjX4AR4T2skQ_tuzylZGOlNVAMHOIlbtjLPKjMjOlUKavKaWze8ZMCIvN824GkKIox3Ar1FGS4RcEr2yEXmUFNnMU9mORpSyLEqjnvy_8xfk1qQ-njbTdycfnpLbgV4-ZAvwYodsrRZreIYgZNU9jzPtF_0B3jc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA9aofgi9bPXVo3ga-ptNvsRX0q5elStpegV7m3ZJLNQqZvzPkr1X_Sf6kySngri27KZTWCTmfwmM5kfY6-NzaFzkgiIh4VQ2mTCtC4TtSlA2bx0nQtZvqfl8bn6MC2mKf9pkdIqb21iMNTOWzojfxMCPqgS6MB3KS3i7Gh8MPsuiEGKIq2JTuMuu4e75JDYDKrp2vkq0FaHm0ZVXgh8rmO9TSmpwM_q6_5Vpi_2K5kIWP6JNMOOM95iDxJU5Idxbh-yO9A_YpufUjD8Mfs1WnMIct9xRHI81iJOBoxens1BrNBGRt55_gU3qksQzi-An8CV7y79dYu9cTqO5UTc-6f0XxIIbvkEJx74UftjwUMSHTi-9GFgNDORnZQGPZ-HS758QjewsCmme_Vv-SH_3PbOf7v4iV-OYpI8SqEKPGGT8bvJ6FgkbgYxqxX-QVfaLkMwB3llDaCb1WVl5RA9GKlcVjlJAUZt8zbXNYJKaGUlFUJNQJcJyjZ_yjZ638M240ZRKHBoC1tr5XRdA5DNRdxqtLOFHrC92wlpkn4tmt-rYcBerZtRMyjc0fbgVyhTKYRfCj20AXsWJ7KZxRIeTV6qMit1sfP_zl-yTVxkzcn704-77D4xzVPigMz22MZyvoLniEeW5kVYaDcLSOJj |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+the+Effectiveness+of+Pre-urodynamic+Single-dose+Levofloxacin+with+Post-urodynamic+Levofloxacin+for+Three+Days+Related+to+the+Incidence+of+Urinary+Tract+Infection%3A+A+Randomized+Control+Trial&rft.jtitle=Urology+journal&rft.au=Rahardjo%2C+Harrina+Erlianti&rft.au=Fina+Widia&rft.au=Mega+Anara+Manurung&rft.au=Wicaksono%2C+Indra&rft.date=2023-05-21&rft.pub=Urology+and+Nephrology+Research+Center&rft.issn=1735-1308&rft.eissn=1735-546X&rft.volume=20&rft.issue=3&rft.spage=167&rft_id=info:doi/10.22037%2Fuj.v19i.7288&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1735-1308&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1735-1308&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1735-1308&client=summon |